Fasnall (benzene<wbr/>sulfonate)

Fasnall (benzenesulfonate)

CAT N°: 19957
Price:

From 66.00 56.10

Fasnall is an inhibitor of fatty acid synthase (FASN) with an IC50 value of 3.71 ?M for the human recombinant enzyme.{31546} It inhibits tritiated acetate incorporation into lipids (IC50 = 5.84 ?M), increases ceramide accumulation, and induces the formation of lipid droplets in BT474 HER2+ breast cancer cells. Fasnall has antiproliferative activity against non-tumorigenic MCF-10A and tumorigenic MCF-7, MDA-MB-468, BT474, and SK-BR-3 breast cancer cells that directly correlates to the level of FASN expression in vitro. It reduces tumor volume and increases survival in the murine MMTV-Neu model of HER2+ breast cancer. Fasnall also potentiates carboplatin (Item No. 13112) response in vivo, increasing the objective response rate of stable disease from 25% for carboplatin alone to 88% for carboplatin with fasnall.

We also advise you